Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Diabetes, Obesity & Metabolism
|
January 12, 2005
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients
G Derosa, A F G Cicero, G Murdolo, et al.
The American Journal of Cardiology
|
October 29, 1992
Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group
G Mancia, R De Cesaris, R Fogari, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1994
Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment: focus on ACE inhibitors
A Ravogli, S Omboni, R De Cesaris, et al.
Journal of Cardiovascular Pharmacology
|
October 23, 1997
Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone
R Fogari, L Corea, O Cardoni, et al.
Minerva Cardioangiologica
|
March 1, 1992
[The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]
E Ambrosioni, A Brusca, S Caponnetto, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)
F R Bühler, G Berglund, O K Anderson, et al.
Journal of Cardiovascular Pharmacology
|
June 3, 2000
Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients
G Mancia, S Omboni, E Agabiti-Rosei, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
G Derosa, E Fogari, A D'Angelo, et al.
Journal of Hypertension
|
February 12, 1998
24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group
R Fogari, S Ambrosoli, L Corradi, et al.
Circulation
|
March 18, 1997
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation
G Mancia, A Zanchetti, E Agabiti-Rosei, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Diabetes, Obesity & Metabolism
|
January 12, 2005
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients
G Derosa, A F G Cicero, G Murdolo, et al.
The American Journal of Cardiology
|
October 29, 1992
Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group
G Mancia, R De Cesaris, R Fogari, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1994
Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment: focus on ACE inhibitors
A Ravogli, S Omboni, R De Cesaris, et al.
Journal of Cardiovascular Pharmacology
|
October 23, 1997
Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone
R Fogari, L Corea, O Cardoni, et al.
Minerva Cardioangiologica
|
March 1, 1992
[The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]
E Ambrosioni, A Brusca, S Caponnetto, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1986
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS)
F R Bühler, G Berglund, O K Anderson, et al.
Journal of Cardiovascular Pharmacology
|
June 3, 2000
Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients
G Mancia, S Omboni, E Agabiti-Rosei, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
G Derosa, E Fogari, A D'Angelo, et al.
Journal of Hypertension
|
February 12, 1998
24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group
R Fogari, S Ambrosoli, L Corradi, et al.
Circulation
|
March 18, 1997
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation
G Mancia, A Zanchetti, E Agabiti-Rosei, et al.
Page
of 18